4 year-old Sofia and her family were granted humanitarian parole to come to the U.S. to receive life-saving treatment for her rare medical condition. But now the Trump administration has ordered them ...

The Digital Dose Inhalers Market is set for strong growth through 2031, driven by rising respiratory diseases and demand for smart, accurate drug delivery. Sai Kiran DataM Intelligence 4Market ...

The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, techno ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 billion by 2034. The Industry is expected to surge at a CAGR of 3.70% from ...

Lupin is now utilizing Honeywell’s Solstice Air in its respiratory inhalers, significantly improving respiratory care with ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

Lupin partners with Honeywell to revolutionise respiratory care with eco-friendly propellant, reducing greenhouse gas emissions significantly.